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rhythmicity comprises proteins whose interplay
generates time-specific transcription of clock
genes. The role of chromatin remodeling in a
physiological setting such as the circadian
clock is yet unclear. We show that the protein
CLOCK, a central component of the circadian
pacemaker, has histone acetyltransferase (HAT)
activity. CLOCK shares homology with acetyl-
coenzyme A binding motifs within the MYST
family of HATs. CLOCK displays high sequence
similarity to ACTR, a member of SRC family
of HATs, with which it shares also enzymatic
specificity for histones H3 and H4. BMAL1,
the heterodimerization partner of CLOCK, en-
hances HAT function. The HAT activity of
CLOCK is essential to rescue circadian rhyth-
micity and activation of clock genes in Clock
mutant cells. Identification of CLOCK as a novel
type of DNA binding HAT reveals that chromatin
remodeling is crucial for the core clock mecha-
nism and identifies unforeseen links between
histone acetylation and cellular physiology.
INTRODUCTION
Several histone modifications contribute to chromatin
remodeling and thereby to the control of a large array of
nuclear processes (Cheung et al., 2000; Felsenfeld and
Groudine, 2003). Histone acetylation is believed to play a
pivotal role in the modulation of chromatin structure asso-
ciated with transcriptional activation (Grunstein, 1997; Kuo
and Allis, 1998; Struhl, 1998; Wade and Wolffe, 1997;
Workman and Kingston, 1998). In support of this notion,
a wide variety of nuclear proteins involved in transcriptional
control have been demonstrated to possess intrinsic his-
tone acetyltransferase (HAT) activity (Kouzarides, 1999;
Roth et al., 2001; Sterner and Berger, 2000). In particular,
a number of transcriptional coactivators, including GCN5(Brownell et al., 1996), PCAF (Yang et al., 1996), CBP/p300
(Bannister and Kouzarides, 1996; Ogryzko et al., 1996),
SRC-1 (Spencer et al., 1997), and ACTR (Chen et al.,
1997) are known to acetylate histones, thereby facilitating
the transactivation exerted by a number of DNA binding
transcription factors. Furthermore, HAT function is not lim-
ited to coactivators. Indeed, HAT function has been as-
cribed also to TAFII250, a component of the TATA box
binding TFIID complex of the basal transcription machin-
ery (Mizzen et al., 1996), and to ATF-2, a sequence-specific
DNA binding transcription factor (Kawasaki et al., 2000).
Amino acid sequence analyses of HAT proteins reveal an
important feature: HATs fall into distinct families that share
relatively poor sequence similarity. For example, ACTR/
SRC-1 is thought to constitute a unique class of HATs
(Chen et al., 1997; Spencer et al., 1997), whereas p300/
CBP displays only limited homology to the GCN5-related
N-acetyltransferase superfamily (Martinez-Balbas et al.,
1998). The MYST family of HATs is particularly interesting
as these proteins show similarity with other acetyltrans-
ferases exclusively within the acetyl-coenzyme A binding
motif (denominated ‘‘motif A’’; Yamamoto and Horikoshi,
1997). Accumulating evidence indicates that histone acet-
ylation exerted by various classes of HATs contributes to
plasticity in transcriptional control by increasing the dy-
namic changes in chromatin structure (Fischle et al., 2003).
Finely controlled transcriptional regulation is the central
feature of circadian clock function. About 10% of all mam-
malian transcripts undergo circadian fluctuations in abun-
dance (Akhtar et al., 2002; Duffield et al., 2002; Panda
et al., 2002). These oscillations are driven by cell-autono-
mous pacemakers present in the central clock structure,
the suprachiasmatic nucleus (SCN) of the hypothalamus,
and in most peripheral tissues (Schibler and Sassone-
Corsi, 2002). Such a unique temporal regulation of tran-
scription elects the cellular clock as a prominent model
for the study of dynamic regulations of chromatin remod-
eling (Crosio et al., 2000). Moreover, as circadian rhythms
are tightly coupled to physiological and metabolic control
(Rutter et al., 2002; Schibler and Naef, 2005), clock-
controlled chromatin reorganization is likely to reveal yet
unexplored pathways linking histone modifications to
cellular metabolism.Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc. 497
The molecular framework of the circadian clock ma-
chinery is constituted by a network of transcription/trans-
lation-based autoregulatory feedback loops (Cermakian
and Sassone-Corsi, 2000; Dunlap, 1999; King and Taka-
hashi, 2000; Reppert and Weaver, 2002; Young and Kay,
2001). The basic helix-loop-helix-Per/Arnt/Sim (bHLH-
PAS) transcription factor, CLOCK acts as master control-
ler serving as a positive regulator in the primary feedback
loop (Darlington et al., 1998; Gekakis et al., 1998). In mice,
mCLOCK forms heterodimers with mBMAL1 and drives
transcription of Period (mPer1, mPer2, and mPer3) and
Cryptochrome (mCry1 and mCry2) genes through E box
elements located in their promoter regions. The mPER
and mCRY proteins then negatively feedback to repress
their own transcription by acting on the mCLOCK:
mBMAL1 complex. This negative-feedback regulation
also drives gene expression cycles of a variety of circadian
output genes (Lowrey and Takahashi, 2004).
The activation of clock-controlled genes by mCLOCK:
mBMAL1 was recently shown to be coupled to circadian
changes in histone acetylation at their promoters (Curtis
et al., 2004; Etchegaray et al., 2003; Ripperger and Schi-
bler, 2006), indicating that transcription-permissive chro-
matin states are dynamically established in a circadian
time-specific manner. The molecular dissection of the
mCLOCK:mBMAL1-mediated transactivation mechanism
is likely to provide significant information on how circadian
regulation of histone acetylation is achieved. Several lines
of genetic evidence indicate that the carboxy-terminal glu-
tamine-rich region of CLOCK exerts a central function in
the circadian transactivation of target genes in flies and
mice (Allada et al., 1998; Antoch et al., 1997; Gekakis
et al., 1998; Jin et al., 1999; King et al., 1997). Yet, the
molecular mechanisms linking CLOCK to circadian his-
tone acetylation and a transcription-permissive chromatin
structure has remained elusive.
Here, we show that CLOCK has intrinsic HAT activity.
Analysis of the primary structure of CLOCK revealed that
the carboxy-terminal glutamine-rich region presents high
sequence similarity to ACTR, a member of SRC family of
HATs. The acetyl-coenzyme A binding motif shows high
similarity to Esa1, a yeast protein of the MYST family of
HATs. Mutations of this putative acetyl coenzyme A bind-
ing site generated mutant CLOCK proteins that display
a drastic reduction in histone acetyltransferase activity.
Differently from normal CLOCK, ectopic expression of
CLOCK mutants is unable to rescue circadian gene rhyth-
micity in Clock mutant MEF cells. These data underscore
the physiological relevance of CLOCK-mediated histone
acetylation as a chromatin-remodeling event required for
circadian clock function.
RESULTS
Conserved Structural Features between
CLOCK and HATs
We have been studying the transcriptional activation func-
tion of CLOCK and analyzed the protein primary structure,498 Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc.focusing our attention on the carboxy-terminal glutamine-
rich region that was previously shown to be implicated
in transactivation function (Allada et al., 1998; Gekakis
et al., 1998). Except for a polyglutamine stretch, no charac-
teristic structural motifs were previously described in this
region (Figure 1A). Our extensive search has revealed that
the carboxy-terminal region of CLOCK displays a signifi-
cant sequence homology with the carboxy-terminal do-
main of ACTR (Figure 1B), a domain previously described
to have intrinsic HAT activity (Chen et al., 1997). In this re-
gion at least six independent amino acid regions are found
to share significant sequence similarity between the two
proteins. Importantly, the amino acid residues common to
CLOCK and ACTR are evolutionarily conserved in both
proteins (Figure 1B). It is also noteworthy that CLOCK and
ACTR share a number of other structural features outside
of the carboxy-terminal glutamine-rich region. These in-
clude the highlyconservedbHLH-PASdomain at the amino
termini, a NRID (nuclear receptor interaction domain), as
well as serine-rich regions within the middle portion of
bothproteins (Figure1A).AlthoughCLOCKisasignificantly
smaller protein as compared to ACTR, these common fea-
tures result in a strikingly similar organization overall. Anal-
ysis of the primary sequence shows that BMAL1, the het-
erodimeric partner of CLOCK, which is also a bHLH-PAS
domain-containing protein (Hirayama and Sassone-Corsi,
2005), displays no similarity to the HAT region of ACTR.
CLOCK Has HAT Activity
The presence of conserved structural features common to
CLOCK and ACTR prompted us to test whether the
CLOCK protein has the ability to acetylate histones. We
transiently expressed a Myc-tagged mCLOCK (Myc-
mCLOCK) in cultured mammalian cells and prepared cell
extracts. CLOCK was found to have significant HAT activ-
ity in immunoprecipitates obtained using a specific anti-
Myc antibody (Figure 2A, right). In contrast, Myc-mBMAL1
yielded little or no HAT activity, comparable to that
observed in immunoprecipitates prepared from mock-
transfected cells. Immunoblot analysis confirmed that the
expression levels of Myc-mBMAL1 and Myc-mCLOCK
proteins were equivalent (Figure 2A, left). Thus, the immu-
noprecipitated HAT activity is specific to mCLOCK and
not to its heterodimeric partner mBMAL1.
To unequivocally establish that CLOCK is a protein ex-
hibiting HAT activity in the Myc-mCLOCK immunoprecip-
itate, we performed in-gel HAT assays using a mixture of
purified histones as substrate (Brownell et al., 1999). After
transient expression in mammalian cells, Myc-mCLOCK
was immunoprecipitated and purified. Proteins resolved
by SDS-PAGE were subjected to in-gel enzymatic reac-
tion. Detection of histones [14C]-acetylated in situ demon-
strated that acetylation took place specifically in a position
corresponding to where the Myc-CLOCK protein migrated
(Figure 2B, lanes 2 and 5). To confirm this result, and
to rule out the possibility that a contaminant HAT comi-
grating with Myc-CLOCK would be responsible for the
acetylation, we used an N-terminally truncated mCLOCK
Figure 1. Comparison of Primary Struc-
tures of CLOCK and ACTR
(A) Schematic representation of the primary
structures of mouse CLOCK and human ACTR
with common features; a basic helix-loop-helix
(bHLH) motif, Per-Arnt-Sim (PAS) domains,
serine-rich (S-rich) regions, a nuclear receptor
interaction domain (NRID), a glutamine-rich
(Q-rich) region containing a poly-glutamine
(polyQ) stretch. A horizontal line above hACTR
indicates a region known to have HAT activity.
(B) Amino acid sequences of the carboxy-
terminal glutamine-rich region of CLOCK from
various species (upper; shown for zebrafish is
zCLOCK3) and amino acid sequences of the
HAT domain of ACTR from various species
(lower). Identical or chemically similar residues
shared by CLOCK and ACTR proteins are
shown by colored backgrounds, with each of
the homologous amino acid stretches high-
lighted by distinct colors. Residues evolution-
ally conserved only within CLOCK or ACTR
proteins are shown on gray-shaded back-
grounds. A horizontal line above the CLOCK
sequences indicates a region homologous to
the acetyl-CoA binding motif.(Myc-mCLOCKDN) protein in the in-gel HAT assay. This
truncated CLOCK protein lacks the N-terminal residues
1–242 but has an intact C-terminal region and still displays
efficient HAT activity in the gel (Figure 2B, lanes 3 and 6).
These results demonstrate that CLOCK is a HAT.
BMAL1might modulateCLOCK-dependent HATactivity.
To test this possibility, Myc-mCLOCK and Myc-mBMAL1
were transiently coexpressed and then coimmunoprecipi-
tated. In the presence of mBMAL1, the relative HAT activity
of mCLOCK was enhanced by about 4-fold (Figure 2C).
This is particularly interesting as binding to E boxes and
additional regulatory levels of control require the formation
of the CLOCK:BMAL1 heterodimer (Gekakis et al., 1998;
Hogenesch et al., 1998; Rutter et al., 2001). It should be
noted that protein analysis revealed that CLOCK levels are
generally reduced by the presence of BMAL1 (not shown),
as predicted since CLOCK:BMAL1 heterodimerization in-
duces protein degradation (Kondratov et al., 2003).
Acetyl-CoA Binding Motif in CLOCK
Acetyl-coenzyme A (CoA) binding motifs are hallmarks of
HAT proteins (Sterner and Berger, 2000). Detailed se-quence comparison between the acetyl-CoA binding mo-
tifs of various HATs revealed that CLOCK contains a motif
within the carboxy-terminal glutamine-rich region (Fig-
ure 3A). This amino acid sequence stretch shares signifi-
cant similarity to the so-called ‘‘motif A’’ in the HAT family
denominated MYST (for its founding members MOZ, Ybf2/
Sas3, Sas2, and Tip60). In particular, mCLOCK shows
high sequence similarity to yeast Esa1 and other MYST
members, including yeast Sas3, fly MOF, and human
Tip60. Importantly, the same residues that have been
demonstrated by crystal structure analysis of the Esa1
protein to be involved in acetyl-CoA interaction (Yan
et al., 2000) are shared with mCLOCK (Figure 3A, indi-
cated by open circles above the sequence). It is significant
that these residues are all fully conserved in CLOCK pro-
teins of various species (Figure 1B). One remarkable fea-
ture of the motif A in CLOCK, when compared to MYST
family members, is the insertion of five amino acids—
also fully conserved among species (Figure 1B). As com-
pared to Esa1, the additional five amino acids would
lengthen the loop comprised between b9 and a3, a region
that is demonstrated to be exposed at the protein surfaceCell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc. 499
Figure 2. HAT Activity Displayed by
Immunoprecipitated Myc-mCLOCK
(A) Myc-mCLOCK-specific immunoprecipita-
tion of HAT activity. Myc-mCLOCK or Myc-
mBMAL1 were transiently expressed in JEG3
cells and then immunoprecipitated with anti-
Myc 9E10 antibody. After extensive washing,
the resulting immunoprecipitates were incu-
bated with [3H] acetyl-CoA and a mixture of his-
tone H3 and H4 amino-terminal tail peptides.
The incorporated [3H] acetate was detected
by filter binding assays. As a control, cells
transfected with an empty vector (mock) were
also subjected to the immunoprecipitation-
HAT assay. Representative Western blot, illus-
trating the protein levels of the immunoprecip-
itated Myc-tagged proteins, is shown on the
left. Data shown are the means ± range of var-
iation from two independent experiments.
(B) In-gel HAT activities of Myc-CLOCK. Either
a full-length (Full) or an N-terminally truncated
(DN) mCLOCK protein was expressed in JEG3
cells and immunoprecipitated as described in
(A). The immunoprecipitates were resolved on
a 7.5% SDS-PAGE gel containing core his-
tones and processed to detect acetyltransfer-
ase activity (left). Identical immunoprecipitated
samples were electrophoresed in a parallel
SDS-PAGE gel and immunoblotted with anti-
Myc 9E10 antibody (right).
(C) Positive effect of BMAL1 coexpression on
CLOCK HAT activity. Myc-mCLOCK was ex-
pressed in JEG3 cells in the presence or ab-
sence of Myc-BMAL1. Immunoprecipitation-
HAT assays were done as described in (A).
The relative amount of Myc-CLOCK protein
added to each HAT reaction was determined
by immunoblot analyses with anti-Myc 9E10
antibody. The HAT activities shown were nor-
malized with the amounts of Myc-CLOCK pro-
tein after subtraction of the background HAT
activities derived from the mock immunopre-
cipitates. Data shown are the means ± range
of variation from two independent experiments.(Yan et al., 2000). Predictions indicate that changes in the
length of these loops can be well accommodated without
gross perturbation of the protein structure (Protein Data
Bank, http://rutgers.rcsb.org/pdb/), yet they might be
associated to differences in the physiological function of
these HAT molecules. Intriguingly, the putative acetyl-
CoA binding motif in Drosophila CLOCK lacks the five
extra amino acids present in the vertebrate counterparts
(Figure 3A), which increases its similarity to Esa1 and other
MYST family members. Finally, a number of acetyl-CoA
binding motifs from various N-acetyltransferases also
show similarities.
Mutations in the Motif A Reduce HAT Activity
To validate the functional role of the acetyl-CoA binding
motif, we generated a mCLOCK mutant with a short dele-
tion that removes part of the homology (DA, residues 656–
665, indicated by a horizontal line above the sequence in500 Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc.Figure 3A). We assayed purified recombinant proteins
generated with the baculovirus system (Figure 3B). Full-
length mCLOCK and the mutant mCLOCKDA were
tagged with hexahistidine residues together with a FLAG
epitope (His-FLAG-mCLOCK). Expression in Sf9 cells was
in combination with nontagged mBMAL1. We found that
mCLOCK is not readily solubilized because of protein
aggregation, an effect significantly decreased by the pres-
ence of mBMAL1 (data not shown). Recombinant proteins
were first purified by Ni-NTA beads and further purified
over FLAG antibody affinity beads. Tandem affinity-puri-
fied proteins were subjected to HAT assays as well as
SDS-PAGE followed by silver staining. Equivalent levels of
soluble His-FLAG-mCLOCK and His-FLAG-mCLOCKDA
proteins were both purified as heterocomplexes with non-
tagged mBMAL1 (Figure 3B, left). HAT assays showed
that His-FLAG-mCLOCK exhibited significant acetyltrans-
ferase activity toward free core histones but not bovine
Figure 3. CLOCK Has an Acetyl-CoA
Binding Motif Required for HAT Activity
(A) Sequence alignment of CLOCK with acetyl-
CoA binding motifs from various acetyltrans-
ferases. Identical or chemically similar residues
to mouse CLOCK are shown with red back-
grounds. Residues shared only with Drosophila
CLOCK are shown with yellow backgrounds.
Both mCLOCK and dCLOCK show sequence
similarity to the acetyl-CoA binding motifs of
MYST family of HATs (yeast Esa1, yeast
Sas3, Drosophila MOF, and human TIP60)
and some of theN-acetyltransferases (Strepto-
myces puromycin NAT, E. coli spermidine NAT,
E. coli ribosomal NAT). Open circles above the
sequence indicate the residues interacting with
acetyl-CoA in crystallized Esa1 protein (Yan
et al., 2000), which shows the highest similarity
to mCLOCK. A horizontal line above the se-
quences indicates the residues deleted in
mCLOCKDA mutant protein.
(B) HAT activity displayed by baculovirus-
generated CLOCK protein. Either His-FLAG-
mCLOCK or His-FLAG-mCLOCKDA was ex-
pressed in Sf9 cells together with non-tagged
mBMAL1. The recombinant proteins were first
purified by Ni-NTA beads and further purified
over FLAG antibody affinity beads. The tandem
affinity-purified proteins were separated on a
13% SDS-PAGE gel and subjected to silver
staining (left). The affinity-purified recombinant
proteins were incubated with either free core
histones or BSA in the presence of [3H]
acetyl-CoA. The incorporated [3H] acetate
was detected by filter binding assays (right).
Data shown are the means ± range of variation
from two independent experiments.
(C) HAT activities of motif A mutants. Immuno-
precipitation-HAT assays were done with Myc-
mCLOCK mutants (mut A and mut B) carrying
mutation at the indicated residues in the motif
A (left). The HAT activities were determined
by filter binding assays as described in Fig-
ure 2C (right). Reduced HAT activities were ob-
tained from the mutants (mut A and mut B) as
well as Myc-mCLOCKDA. Data shown are the
means ± range of variation from two indepen-
dent experiments.serum albumin (Figure 3B, right). In contrast, His-FLAG-
mCLOCKDA displayed a drastically reduced HAT activity,
although its heterodimerization capacity with BMAL1 was
intact (Figure 3B, left). These results indicate that the in-
tegrity of the acetyl-CoA binding motif is required for the
HAT enzymatic activity of mCLOCK.
The reduction in HAT activity of mCLOCKDA mutant
was confirmed using proteins immunoprecipitated from
cultured cells (Figure 3C). Myc-mCLOCKDA exhibited
a significant reduction of enzymatic activity, either in the
presence or absence of Myc-mBMAL1 (Figure 3C). To
identify specific residues essential for HAT function, we
generated two additional mutants of the motif A. Each mu-
tant carries three single amino acid substitutions into ala-
nine of the highly conserved residues implicated in theacetyl-CoA interaction (mut A and mut B, Figure 3C,
left). HAT assays demonstrated that both mutants display
drastically reduced enzymatic activity, comparable to the
mCLOCKDA mutant. All together these data show that the
integrity of the motif A within the MYST homology stretch
of mCLOCK is required for HAT enzymatic activity.
Specificity of CLOCK-Mediated Acetylation
Next, we wished to establish the identity of the histones
that are acetylated by mCLOCK. To do so, HAT assays us-
ing either free core histones or mononucleosomes were
performed and the reaction products analyzed on SDS-
PAGE (Figure 4A). The mCLOCK protein acetylated
primarily histones H3 and H4 on both free histone and
mononucleosomes, demonstrating a significant degreeCell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc. 501
Figure 4. AcetylationProfilesofmCLOCK
(A) Substrate specificity of His-FLAG-mCLOCK:
mBMAL1. Free core histones (lanes 1 and 2) or
mononucleosomes (lanes 3 and 4) were incu-
bated with BSA (lanes 1 and 3) or recombinant
His-FLAG-mCLOCK:mBMAL1 (lanes 2 and 4).
[14C]-acetylated histones were resolved by
SDS-PAGE, and the gels were stained with
Coomassie brilliant blue (CBB) and analyzed
by fluorography.
(B) Acetylation site specificity. Filter binding
assays were done as described in (A), except
that synthetic histone amino-terminal peptides
shown on the left were utilized as substrates.
Sites where 3-N-acetyllysine was incorporated
during peptide synthesis in order to mimic
sites that are acetylated in vivo are indicated
by closed boxes. Data shown are the means ±
range of variation from two independent ex-
periments.of specificity. Interestingly, this substrate specificity is
analogous to that of ACTR (Chen et al., 1997), extending
the similarity between the two proteins from structural
(Figure 1) to functional.
Specificity of CLOCK enzymatic activity was then inves-
tigated by using H3 and H4 tails with preacetylated ly-
sines. In this approach, putative HAT substrate sites are
occupied, resulting in a block of potential de novo acety-
lation (Mizzen et al., 1996). Our results determined that
histone H3 Lys-14, and in a lesser extent Lys-9, are the
major sites acetylated by mCLOCK (Figure 4B). Additional
support to this finding is provided by chromatin immuno-
precipitation assays described below (Figure 5C). Block
of multiple putative lysines in either H3 and H4 results in
a complete lack of acetylation, supporting the notion
that these histones are natural CLOCK targets. As acety-
lation at H3 Lys-14 has been intimately coupled to tran-
scriptional activation (Fischle et al., 2003), our findings
stress the positive role that the HAT function of CLOCK
plays within the clock mechanism.
The HAT Function of CLOCK Is Essential
for Circadian Regulation
We next wanted to establish whether the HAT function of
CLOCK is required for circadian rhythmicity (Figure 5). As
experimental system we used mouse embryonic fibro-
blast (MEF) cells derived from homozygous Clock mutant
(c/c) mice (Vitaterna et al., 1994). As Clock is essential for
circadian rhythm (Antoch et al., 1997; King et al., 1997),
MEF c/c cells show no cyclic expression of clock genes
(Pando et al., 2002). We first tested whether ectopic ex-
pression of mCLOCK is able to rescue the circadian ex-
pression of endogenous target genes. MEF c/c cells502 Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc.stably transfected with a mCLOCK expression plasmid
were subjected to a serum shock, a stimulus commonly
used to trigger circadian gene transcription in a variety
of cell lines (Balsalobre et al., 1998; Pando et al., 2002).
While the MEF c/c cells had no functional circadian clock,
ectopic expression of mCLOCK restored circadian ex-
pression of the endogenous mPer1 gene 20 hr after
the serum shock (Figure 5B, left). Similarly, circadian ex-
pression of Dbp, an E box-regulated circadian output
gene, was also rescued (Figure 5B, right). Rescue of circa-
dian transactivation in MEF c/c cells was lesser when
compared to wild-type MEF cells (see Figure S1 in the
Supplemental Data available with this article online). This
is most likely due to a semi-dominant-negative effect of
the mutant CLOCK protein endogenously expressed in
MEF c/c cells (Vitaterna et al., 1994; Yoo et al., 2005). As
predicted (Gekakis et al., 1998), ectopic expression of a
mCLOCK mutant carrying the deletion of exon 19 (D19)
resulted in no complementation (Figure S2).
These cell-based studies enabled us to analyze the in-
volvement of the HAT function in the chromatin-based
transcriptional control of clock genes. We found that the
ectopic expression of HAT-deficient mCLOCK (mCLOCK-
mut A, Figure 5B, and mCLOCKDA, Figure S2) failed to
restore the circadian transactivation of mPer1 and Dbp.
Importantly, the lack of rescuing by mCLOCK-mut A was
associated to a significant reduction of histone H3 acety-
lation on the mPer1 promoter (Figure 5C). Chromatin
immunoprecipitation (ChIP) assays established that H3
acetylation at lysines K9/K14 on the mPer1 promoter
was elevated at the transcription-active time point (16 hr
post-serum shock) in the MEF c/c cells ectopically
expressing wild-type mCLOCK (Figure 5C, lane 10).
Figure 5. Ectopic Expression of
mCLOCK mut A Is Unable to Comple-
ment Circadian Expression of mPer1
and Dbp in c/c MEFs
(A) Establishment of stable cell lines. MEF c/c
cells were stably transfected with either a
wild-type (+wt) or mutant (+mutA) form of Myc-
mCLOCK. Shown are immunoblot analyses
with anti-mCLOCK antibody (left) or anti-Myc
9E10 antibody (right). Arrowheads indicate the
ectopically expressed proteins, whose levels
were equivalent to the endogenously ex-
pressed mCLOCKD19 mutant.
(B) Serum shock-dependent circadian transac-
tivation of mPer1 and Dbp. Cells were sub-
jected to a 2 hr exposure to 50% horse serum
and then placed in 0.5% serum medium. Total
RNA was isolated from the cells harvested at
the indicated time points, and expression
levels of mPer1 and Dbp were estimated by
quantitative real-time PCR. Values were nor-
malized to the expression of Sumo-3, a nono-
scillating gene (Cardone et al., 2005), and plot-
ted as relative fold of expression at time 0 (set
as 1) in Clock c/c MEFs. Mean values of four in-
dependent experiments are shown, with range
variations (SD).
(C) Histone H3 acetylation at mPer1 promoter.
MEF c/c cells stably expressing a wild-type
(+wt) or mutant (+mut A) form of myc-mCLOCK
were harvested at 6 and 16 hr post-serum
shock and subjected to ChIP assays. Shown
are representative results from quantitative
PCR analysis of inputs (lanes 1–4) and DNA im-
munoprecipitated with normal rabbit IgG (lanes
5–8) and antiacetylated histone H3 at lysines 9
and/or 14 (lanes 7–12). Relative PCR values of
acetyl H3 were normalized to the inputs and the
value of time 6 in the +wt cells was set to 1.
Plotted values are the mean ± SD from three in-
dependent experiments.
(D) Recruitment of CLOCK and coactivators to
the E box of mPer1 promoter. The indicated
cells were harvested 16 hr post-serum shock
and subjected to ChIP assays. Shown are rep-
resentative results from quantitative PCR anal-
ysis using inputs (lanes 1 and 2) and DNA im-
munoprecipitated with anti-Myc (lanes 5 and
6), anti-PCAF (lanes 7 and 8), anti-CBP (lanes
9 and 10), and anti-TIP60 (lanes 11 and 12).
The samples incubated without antibody (lanes
3 and 4) gave no PCR product. PCR analyses
were done with a linear correlation between
the amplified products and the starting
amounts of template DNA (lanes 13–15).Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc. 503
However, in cells ectopically expressing mCLOCK-mut A,
the H3 acetylation was largely reduced (Figure 5C, lane
12). The observed loss of complementation in circadian
transactivation and H3 acetylation was not attributed to
differences in the protein expression or DNA binding
capacity. Indeed, similar levels of wild-type and mutant
proteins were detected in the cell lysates (Figure 5A),
and also mBMAL1expression levels were comparable in
all cells tested (Figure S2). ChIP assays demonstrated
that the efficiency of mCLOCK recruiting to the E box of
mPer1 promoter, as compared to the mutated CLOCK
proteins, is basically equivalent (Figure 5D, lanes 5
and 6). Finally, the single amino acid substitutions in
mCLOCK-mut A, although drastically reducing HAT activ-
ity, have no effect on the association with other transcrip-
tional coactivators, including CBP, PCAF, and TIP60. In-
deed, coimmunoprecipitation assays demonstrated that
mutations in the motif A did not reduce the capacity of
CLOCK to form a complex with CBP, PCAF, and TIP60
(Figure S3). Furthermore, unimpaired recruitment of CBP,
PCAF, and TIP60 coactivators to the E box of mPer1 pro-
moter was confirmed by ChIP assays (Figure 5D, lanes 7–
12). These data strongly indicate that the HAT activity of
CLOCK is essential for circadian control of mPer1 and
Dbp genes.
DISCUSSION
Our study establishes that CLOCK, a master controller of
circadian rhythms, directly modifies chromatin. By dem-
onstrating that CLOCK possesses intrinsic enzymatic
HAT activity, we provide the first evidence that control of
chromatin remodeling constitutes a key regulatory step
governing the circadian clock machinery.
Paradoxical to the central role played by CLOCK in the
rhythmic transcription of the clock-controlled genes, ex-
pression of CLOCK is described to be nearly constitutive
(Lee et al., 2001; Ripperger and Schibler, 2006). Recent
data using chromatin immunoprecipitation assays also
show that CLOCK-containing transcriptional complexes
bind to E box elements constitutively over the circadian
cycles (Lee et al., 2001; Yoo et al., 2005). Our finding of
the enzymatic activity intrinsic to mCLOCK challenges
a view where the CLOCK:BMAL1 heterodimer functions
as a constitutive structural component bound to E box en-
hancers. Rather, CLOCK may exhibit a regulatable HAT
activity that would confer dynamic changes to the local
chromatin environment (Figure 6). One intriguing possibil-
ity could involve circadian time-specific control of the
CLOCK HAT activity by other circadian clock compo-
nents, such as the heterodimeric partner BMAL1 and/or
the PER-CRY negative complex. Indeed, our results indi-
cate that BMAL1 potentiates the HAT function of CLOCK
(Figure 2). We have noted that a bacterially expressed
GST-CLOCK is prone to aggregation with little HAT activ-
ity (data not shown) and that formation of heterocom-
plexes with BMAL1 drastically increases solubility and in
parallel HAT activity (Figures 2 and 3). This would suggest504 Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc.that BMAL1 may critically contribute to structural confor-
mational changes of CLOCK, a scenario reminiscent of
several other HAT proteins that exhibit full activity only
when functioning within a large protein complex in vivo
(Sterner and Berger, 2000).
The HAT function of CLOCK is compatible with previous
studies supporting the recruitment of other HAT coactiva-
tors to the CLOCK:BMAL1 complex (Curtis et al., 2004;
Etchegaray et al., 2003). Rather, different types of HATs
such as ACTR, CBP, and PCAF have been shown to asso-
ciate in unique complexes in vivo (Chen et al., 1997; Yang
et al., 1996), suggesting that a combination of distinct HAT
activities may crucially contribute to orchestrate transcrip-
tional processes in a spatiotemporal specialized manner.
Our results indicate that the HAT activity of CLOCK is es-
sential for temporally regulated transactivation (Figure 5B)
and histone H3 acetylation (Figure 5C). The concerted
contribution of another coactivator(s) is likely to integrate
the complex signaling that governs chromatin remodeling
and the circadian clock machinery.
Figure 6. Schematic Model of CLOCK-Mediated Histone
Acetylation and Its Role within the Physiological Pathways
of Circadian Rhythmicity
The HAT function of CLOCK activity is enhanced by BMAL1, its natural
heterodimerization partner with which it binds to E box promoter ele-
ments within clock gene promoters (such as per1). Acetylation by
CLOCK, for example at H3 Lys-14, is thought to elicit chromatin re-
modeling by inducing a transcription-permissive state. Transcription
mediated by the CLOCK:BMAL1 complex has been shown to be stim-
ulated by other coactivators, such as CBP. Thereby we envisage a sce-
nario where circadian control of chromatin remodeling by CLOCK may
be influenced by the dynamic assembly of a multiprotein regulatory
complex. It is also important to note that metabolic, nutritional, and en-
vironmental circadian cues are likely to modulate the HAT function of
CLOCK.
CLOCK shares homology to the HAT domain of ACTR,
a member of SRC family of HAT proteins (Figure 1). Nota-
bly, these two proteins show marked similarity in regions
outside of the carboxy-terminal domain, displaying a strik-
ingly analogous organization (Figure 1A). CLOCK and all
the members of SRC family (SRC-1, TIF-2, and ACTR)
share a highly conserved bHLH-PAS domain at the amino
termini. These common features appear to define a spe-
cialized class of histone acetylases with a HAT domain
conjugated to a bHLH-PAS domain. However, the
bHLH-PAS domain of ACTR is thought to have no DNA
binding activity (Chen et al., 1997), and a functional contri-
bution of the bHLH-PAS domain to the ACTR HAT activity
has not been reported. The possibility of a direct crosstalk
between the bHLH-PAS and HAT domains necessitates
further investigation within this class of HAT proteins.
Interestingly, the in vitro DNA binding activity of CLOCK:
BMAL1 heterodimer is enhanced in the presence of a re-
duced form of nicotinamide adenine dinucleotide cofactor
through a mechanism mediated by the bHLH-PAS domain
(Dioum et al., 2002; Rutter et al., 2001). This could suggest
a NAD(H)-dependent positive effect on the HAT function
of CLOCK:BMAL1. While this possibility still needs to
be explored, here it is important to recall the case of
transcriptional silencing mediated by NAD(+)-dependent
HDACs (histone deacetylases; Imai et al., 2000; Landry
et al., 2000). Intriguingly, Sir2, a NAD(+)-dependent HDAC,
has been functionally linked to Sas2 (Kimura et al., 2002;
Suka et al., 2002), a protein of the MYST family of HATs
to which CLOCK belongs.
The molecular and physiological implications of our
finding seem numerous. For example, the HAT function
of CLOCK could be regulated by intracellular signaling
pathways, thereby connecting chromatin remodeling to
circadian physiological response (Figure 6). In addition, the
compelling links that exist between circadian cycle and
metabolism (Rutter et al., 2002; Schibler and Sassone-
Corsi, 2002; Turek et al., 2005) suggest that the HAT func-
tion of CLOCK may be controlled by changing cell energy
levels, or conversely, could regulate them. In this respect,
it is notable that CLOCK was found to interact with some
nuclear receptors, including RARa and RXRa (McNamara
et al., 2001), and that periodic availability of nuclear hor-
mones has been implicated in the resetting of peripheral
clocks.
In conclusion, we have identified a novel type of DNA
binding HAT protein, CLOCK, whose activity is required
for circadian clock function. Future work aimed at deci-
phering the rules governing the in vivo dynamic change
of histone acetylation exerted by CLOCK during the day-
night cycle will provide essential new insights into the links
between signaling and the circadian clock. Furthermore,
our studies may provide additional leads for therapeutic
strategies. By controlling its HAT enzymatic activity,
CLOCK would make an ideal target for pharmaceutical
compounds influencing circadian rhythms, sleep, and jet
lag, as well as other physiological and metabolic pro-
cesses under circadian regulation.EXPERIMENTAL PROCEDURES
Plasmids
Construction of FLAG-mCLOCK/pSG5 was described (Travnickova-
Bendova et al., 2002). Myc-mCLOCK/pSG5 was made by replacing
the FLAG epitope in FLAG-mCLOCK/pSG5 with six copies of Myc epi-
tope. Myc-mCLOCKDN was made by deletion of a DNA fragment
encoding the N-terminal part of mCLOCK (residues 1–242) from
Myc-mCLOCK/pSG5. To construct a deletion mutant of the motif A
(DA), a DNA fragment encoding the residues 1–665 of mCLOCK in
Myc-mCLOCK/pSG5 was replaced with a PCR-amplified DNA frag-
ment encoding the residues 1–655. Myc-mCLOCK mutants with three
residues mutated in the motif A (mut A and mut B) were created by us-
ing QuickChange site-directed mutagenesis kit (Stratagene). Con-
struction of Myc-mBMAL1/pCS2 was described (Travnickova-Bend-
ova et al., 2002). All the Myc-tagged proteins contain six copies of
Myc epitope at the amino termini.
Antibodies and Immunoblot
Generation of anti-BMAL1 antibody was described (Cardone et al.,
2005). The other antibodies were either gifts or commercial products;
anti-CLOCK, anti-GCN5, and anti-TIP60 were provided by U. Schibler
(University of Geneva, Switzerland), L. Tora (Institut de Ge´ne´tique et de
Biologie Mole´culaire et Cellulaire, France), and B. Amati (European
Institute of Oncology, Italy), respectively. Purchased were anti-CBP
(A-22, Santa Cruz), anti-p300 (N-50, Santa Cruz), anti-PCAF (E-8,
Santa Cruz), and anti-Myc (9E10, Transduction Laboratories). Immu-
noblot analyses were performed as described (Doi et al., 2004). Pro-
teins samples resolved by SDS-PAGE were immunoblotted, and the
imunoreactivities were visualized by enhanced chemiluminescence
system (NEN) using horseradish peroxidase-conjugatged anti-immu-
noglobulin (Kirkegaard & Perry Laboratories).
Expression and Immunoprecipitation of Myc-mCLOCK
JEG3 cells were cultured in Dulbecco’s modified Eagle’s medium (Life
Technologies) supplemented with 10% fetal bovine serum. Cells
plated in a 10 cm dish were transfected with the indicated combination
of plasmids by using Fugene (Roche). The cells were harvested 36 hr
posttransfection and lysed in 800 ml of solution-I that contains
10 mM NaCl in IP buffer (15 mM HEPES-NaOH [pH 7.8], 10% glycerol,
2 mM EDTA, 1 mM dithiothreitol, 1% Nonidet P-40, 50 mM NaF, 1 mM
sodium vanadate, 1 mM sodium phosphate [pH7.8], 2 mM PMSF,
13 protease inhibitor cocktail). After centrifugation of the lysates at
7003 g for 10 min, the insoluble precipitants were subjected to further
extraction with 800 ml of solution-II that contains 500 mM NaCl in IP
buffer. The soluble protein extracts in solution-I and solution-II were
mixed (1:1) and subjected to immunoprecipitation. After preclearing
with 30 ml of protein G-Sepharose beads, the extract mixture was
incubated with 2.5 mg of anti-Myc 9E10 antibody and 20 ml of protein
G-Sepharose beads at 4ºC for 3 hr. The beads were then rinsed five
times with a washing buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl,
10% glycerol, 2 mM EDTA, 1 mM dithiothreitol, 0.2% Nonidet P-40,
50 mM NaF, 1 mM sodium vanadate, 2 mM PMSF, 13 protease inhib-
itor cocktail), followed by two washes with HAT buffer (10 mM Tris-HCl
[pH 8.0], 100 mM NaCl, 10% glycerol, 0.1 mM EDTA, 1 mM dithiothrei-
tol, 1 mM PMSF). After the final wash, the buffer was aspirated down to
25 ml and subjected to HAT assays as described below. The relative
amount of Myc-CLOCK protein added to each reaction was deter-
mined by immunoblot analyses with anti-Myc antibody.
Expression and Affinity Purification of His-FLAG-mCLOCK
Construction of His-FLAG-mCLOCK was done by cloning a FLAG-
tagged full-length mCLOCK fragment into pAcSG-His NT (Pharmin-
gen), resulting in introduction of double tags (a hexa-histidine tag
and a FLAG epitope) at the amino terminus of mCLOCK. Similarly,
His-FLAG-mCLOCKDA/pAcSG was constructed by using a FLAG-
tagged mCLOCKDA fragment. Neither the hexa-His tag nor theCell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc. 505
FLAG epitope was introduced into mBMAL1/pAcSG construct. Sf9
cells were cultured in Grace’s medium with 10% FBS. Infection was
done using either His-FLAG-mCLOCK or His-FLAG-mCLOCKDA re-
combinant baculovirus together with mBMAL1 recombinant baculovi-
rus. The cells were harvested 48 hr postinfection. Recombinant pro-
teins extracted as described above were first purified by Ni-NTA
beads (Qiagen) and further purified over M2-agarose (Sigma) accord-
ing to the manufacturer’s protocol.
Histone Acetylase Activity Assays
HAT assays were performed as described (Mizzen et al., 1999) by us-
ing either 50 mg of calf thymus core histones (type IIA; Sigma), 5 mg of
HeLa mononucleosome core particles (Loury and Sassone-Corsi,
2004), or 50 mg of synthetic histone amino-terminal peptides (H3, res-
idues 1–20; H4, residues 1–24), in the presence of 50 pmol of [3H]ace-
tyl-CoA (4.3 Ci/mmol, Amersham Life Science) or 300 pmol of
[14C]acetyl-CoA (55 mCi/mmol, Amersham Life Science). The histone
amino-terminal peptide derivatives carrying the preacetylated lysine
residues were also synthesized. Enzymatic reaction was done using
1 pmol of His-FLAG-mCLOCK protein copurified with mBMAL1, and
the HAT activity was determined by liquid scintillation counting of ali-
quots of the reaction mixture spotted onto P-81 filters (Whatman).
For identification of acetylated proteins, aliquots of reaction mixtures
(2 mg of calf thymus core histones or 0.5 mg of HeLa mononucleosome)
were resolved on 14% SDS-PAGE gels and analyzed by fluorography
(Amplify, Amersham Life Science). HAT activity in gel assays were car-
ried out as described (Brownell et al., 1999), except that the electro-
phoresis of immunoprecipitated proteins was done by using a cathode
reservoir buffer supplemented with 0.1 mg/ml calf thymus core his-
tones, and [14C]-acetylated histones were visualized by phosphori-
maging with the aide of a bioimaging analyzer BAS2000 (Fuji Film).
Establishment of Stable Cell Lines and mRNA Expression
Analysis
MEF cells established from homozygous Clock mutant mice were
transfected with a linearized plasmid encoding neomycin and
Myc-tagged mCLOCK. We used an SV40 promoter for the ectopic ex-
pression, as the endogenous mClock gene shows a nearly constitutive
expression over the circadian cycles. Lipofection was done by using
jetPEI (Polyplus-transfection) according to the manufacturer’s proto-
col. Two days later, G-418 (Life Technologies) was added at a final
concentration of 350 mg/ml. After 3 weeks of selection, approximately
100 resistant colonies per transfection were visible. Colonies were
trypsinized and propagated as a single pool, and then pools of clones
were analyzed. Serum-shock experiments were done as described
(Pando et al., 2002). Confluent cells were kept for 2 days in medium
containing 0.5% serum. At t = 0, 50% horse serum was added to the
medium, which was replaced with DMEM containing 0.5% serum after
2 hr. At the indicated times, total RNA was extracted from the cells by
using RNA-Solv (Omega Biotek). Relative mRNA levels of mPer1, Dbp,
andSumo-3were evaluated by quantitative real time PCR (RT-PCR) as
described (Cardone et al., 2005).
Chromatin Immunoprecipitation (ChIP) Analysis
ChIP assays were performed as described (Hirayama et al., 2005). Im-
munoprecipitation of the crosslinked chromatin-protein complexes
was done with the following antibodies: anti-acetylated H3 histone at
lysines 9 and/or 14 (Upstate Biotechnology), anti-CBP (A-22), anti-
TIP60 (a gift from B. Amati), anti-PCAF (H-369, Santa Cruz), and anti-
Myc (9E10). PCR analyses of the 50-flanking region of mPer1 gene
were done by using a primer set described previously (Etchegaray
et al., 2003; Lee et al., 2001), and SYBR Green I-based quantitative
PCR analyses were done as described (Doi et al., 2001). PCR was per-
formed for 23 cycles, a condition optimized for quantitative analyses.
The PCR products were subjected to 6% polyacrylamide gel electro-
phoresis, stained with SYBR Green I (Molecular Probes), and then de-
tected with an image analyzer ChemiGenius XE (SYNGENE). The506 Cell 125, 497–508, May 5, 2006 ª2006 Elsevier Inc.amounts of the products with the predicted size were quantified with
the GeneTool software (SYNGENE).
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cell.com/cgi/content/full/125/3/497/DC1/.
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